PRESS RELEASE published on 02/17/2026 at 12:00, 4 months 20 days ago Press Release: Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease Sanofi and Teva's duvakitug phase 2b maintenance data show durable efficacy in ulcerative colitis and Crohn's disease. Results reinforce ongoing phase 3 programs in UC and CD Ulcerative Colitis Sanofi Teva Crohn's Disease Duvakitug
BRIEF published on 02/16/2026 at 07:05, 4 months 21 days ago Beyfortus proves its effectiveness beyond the first season of VRS Sanofi VRS Beyfortus Infants Immunization
BRIEF published on 02/16/2026 at 07:05, 4 months 21 days ago Beyfortus Shows Extended Benefits for Infants Against RSV Infant Health Beyfortus Hospitalization Reduction RSV Immunization NIRSE-GAL Study
PRESS RELEASE published on 02/16/2026 at 07:00, 4 months 21 days ago Press Release: Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season Universal RSV immunization with Beyfortus reduces hospitalizations in infants across two seasons, as per study in The Lancet Infectious Diseases and RSVVW '26 conference findings RSV Beyfortus Infants Immunization Hospitalizations
BRIEF published on 02/10/2026 at 15:05, 4 months 27 days ago Sanofi Finalizes Acquisition of Dynavax Acquisition Biopharma Sanofi Vaccines Dynavax
PRESS RELEASE published on 02/10/2026 at 15:00, 4 months 27 days ago Press Release: Sanofi completes the acquisition of Dynavax Sanofi completes acquisition of Dynavax, bolstering presence in adult immunization with HEPLISAV-B vaccine and Z-1018 shingles vaccine candidate, enhancing global reach and development capabilities Acquisition Sanofi Vaccine Immunization Dynavax
BRIEF published on 02/03/2026 at 07:05, 5 months 6 days ago Sanofi Signs €1 Billion Share Buyback Mandate Share Buyback Investment Financial Strategy Biopharma Sanofi
PRESS RELEASE published on 02/03/2026 at 07:00, 5 months 6 days ago Press Release: Sanofi announces the signing of a share buyback mandate for up to €1 billion Sanofi signs share buyback mandate for up to €1 billion, intending to repurchase own shares between February 3, 2026, and December 31, 2026 Share Buyback Investment Sanofi Mandate €1 Billion
BRIEF published on 01/30/2026 at 13:05, 5 months 10 days ago Sanofi's Rezurock Recommended for EU Approval by CHMP Sanofi EU Market CHMP Approval Rezurock Chronic GVHD
BRIEF published on 01/30/2026 at 13:05, 5 months 10 days ago The CHMP recommends approval of Sanofi's Rezurock for the treatment of chronic GVHD Treatment Sanofi Rezurock CHAMP GVHD
Published on 07/09/2026 at 23:05, 47 minutes ago Caldwell Reports Third Quarter Results and Announces Increase of Quarterly Dividend
Published on 07/09/2026 at 18:05, 5 hours 47 minutes ago Sky Gold Corp Reports on Gold and Multi-Element Results from Drilling at Evening Star, Nevada
Published on 07/09/2026 at 16:00, 7 hours 52 minutes ago Karbon-X Expands European Compliance Market Capabilities With Spanish EU ETS Registry Account
Published on 07/09/2026 at 19:25, 4 hours 27 minutes ago LIGHTON CHANGES ITS GOVERNANCE WITH THE APPOINTMENT OF JEAN-PHILIPPE BAERT AS CHIEF EXECUTIVE OFFICER AND MARIE DE LAUZON AS CHAIR OF THE BOARD OF DIRECTORS
Published on 07/09/2026 at 18:46, 5 hours 6 minutes ago OHB publishes results of the subscription offer and announces completion of the capital increase
Published on 07/09/2026 at 17:25, 6 hours 27 minutes ago FP Markets: The era of forward guidance coming to an end
Published on 07/09/2026 at 18:00, 5 hours 52 minutes ago Second-quarter 2026 activity: +7% (vs. Q2 2025)
Published on 07/09/2026 at 18:00, 5 hours 52 minutes ago Half-year report on Deezer’s liquidity contract with BNP Paribas
Published on 07/09/2026 at 17:45, 6 hours 7 minutes ago Air Liquide to invest over 200M USD to support chemical manufacturing expansion in Texas
Published on 07/09/2026 at 15:50, 8 hours 2 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of June 30, 2026